Cargando…

Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics

SIMPLE SUMMARY: Lymphoma and other cancers have been studied by mainly focusing on malignant cells. However, research findings about the role of the tumor microenvironment in the progression and immunosuppression of cancer, particularly in lymphomas, have increased considerably in recent years, allo...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Domínguez, Daniel J., Hontecillas-Prieto, Lourdes, Palazón-Carrión, Natalia, Jiménez-Cortegana, Carlos, Sánchez-Margalet, Víctor, de la Cruz-Merino, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946119/ https://www.ncbi.nlm.nih.gov/pubmed/35326620 http://dx.doi.org/10.3390/cancers14061469

Ejemplares similares

Obesity and Risk for Lymphoma: Possible Role of Leptin
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2022)

Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells
por: Sánchez-León, María Luisa, et al.
Publicado: (2023)

The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells
por: Sánchez-León, María Luisa, et al.
Publicado: (2022)

Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021)

Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies
por: Sánchez-Molina, Sara, et al.
Publicado: (2022)

Publisher Correction: Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer
por: Palazón‑Carrión, Natalia, et al.
Publicado: (2021)

Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer
por: Palazón-Carrión, Natalia, et al.
Publicado: (2021)

Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy
por: Sánchez-Margalet, Víctor, et al.
Publicado: (2019)

Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis
por: Palazón-Carrión, Natalia, et al.
Publicado: (2022)

Leptin, Both Bad and Good Actor in Cancer
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021)

Myeloid-derived suppressor cells and vaccination against pathogens
por: Prochetto, Estefanía, et al.
Publicado: (2022)

Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2023)

Possible Role of Leptin in Atopic Dermatitis: A Literature Review
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021)

Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021)

Obesity and Breast Cancer: Role of Leptin
por: Sánchez-Jiménez, Flora, et al.
Publicado: (2019)

Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study
por: de la Cruz-Merino, Luis, et al.
Publicado: (2021)

Long-term complete response to intrathecal trastuzumab in a patient with leptomeningeal carcinomatosis due to her2- overexpressing breast cancer: Case report
por: García, Francisco José Valdivia, et al.
Publicado: (2020)

Obesity as a Risk Factor for Dementia and Alzheimer’s Disease: The Role of Leptin
por: Flores-Cordero, Juan Antonio, et al.
Publicado: (2022)

Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2022)

Role of Leptin as a Link between Asthma and Obesity: A Systematic Review and Meta-Analysis
por: Sánchez-Ortega, Helena, et al.
Publicado: (2022)

Role of Leptin in Non-Alcoholic Fatty Liver Disease
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021)

Expression of nutrient transporters in placentas affected by gestational diabetes: role of leptin
por: Guadix, Pilar, et al.
Publicado: (2023)

Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases
por: Martínez-Chinchilla, Carlos, et al.
Publicado: (2022)

Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study
por: de la Cruz-Merino, L., et al.
Publicado: (2022)

New Insights into the Role of the Immune Microenvironment in Breast Carcinoma
por: de la Cruz-Merino, Luis, et al.
Publicado: (2013)

Role of Sam68 in Post-Transcriptional Gene Regulation
por: Sánchez-Jiménez, Flora, et al.
Publicado: (2013)

Nutrients and Dietary Approaches in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Narrative Review
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021)

Sam68 Mediates the Activation of Insulin and Leptin Signalling in Breast Cancer Cells
por: Pérez-Pérez, Antonio, et al.
Publicado: (2016)

SEOM-GOTEL clinical guidelines on diffuse large B cell lymphoma (2022)
por: Gumà, Josep, et al.
Publicado: (2023)

Resistance mechanisms of immune checkpoint inhibition in lymphoma: Focusing on the tumor microenvironment
por: Zhang, Chunlan, et al.
Publicado: (2023)

Hypoxia Promotes Syndecan-3 Expression in the Tumor Microenvironment
por: Prieto-Fernández, Endika, et al.
Publicado: (2020)

The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma
por: García-Domínguez, Daniel Jose, et al.
Publicado: (2018)

Editorial: B Cell Non-Hodgkin’s Lymphoma & Tumor Microenvironment Crosstalk: An Epigenetic Matter?
por: Denizot, Y, et al.
Publicado: (2022)

Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1
por: García-Domínguez, Daniel J., et al.
Publicado: (2022)

Immune Epigenetic Crosstalk Between Malignant B Cells and the Tumor Microenvironment in B Cell Lymphoma
por: Mondello, Patrizia, et al.
Publicado: (2022)

Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
por: Hontecillas-Prieto, Lourdes, et al.
Publicado: (2020)

Editorial: The regulatory immune system as a target to improve adjuvants and novel vaccines
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2023)

Integrating the Tumor Microenvironment into Cancer Therapy
por: Sanegre, Sabina, et al.
Publicado: (2020)

Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors
por: Vougiouklakis, Theodore, et al.
Publicado: (2020)

Role of Leptin in Inflammation and Vice Versa
por: Pérez-Pérez, Antonio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pi5b53n9j8gejck43ksgao1j1r